Rabeprazole Sodium
Product Images NDC 50090-1424

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-1424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 01)

FDA Label Image

Image-02 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 02)

Image-02 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 02)
This text represents a chart or table that compares the mean heartburn scores of three different groups (placebo, RAB 10mg, and RAB 20mg) over a period of 28 study days. The heartburn scores range from 0 (no heartburn) to 4 (very severe heartburn).*
FDA Label Image

Image03 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 03)

Image03 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 03)
This text appears to be a table showing mean score and heartburn scores for three different treatments - placebo, RAB 10mg, and RAB 20mg. The numbers in the table represent the mean heartburn score for each treatment, with a score of 0 indicating no heartburn.*
FDA Label Image

Image-04 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 04)

Image-04 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 04)
The text is a table displaying the mean score for Heartoum Scores for a study with two groups: Placebo (n=58) and RAB20mg (n=59), measured on study days 0, 7, 14, 21, and 28. The Heartoum Scores range from 0 to 4, with 0 indicating no symptoms and 4 indicating very severe symptoms.*
FDA Label Image

Image05 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 05)

Image05 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 05)
The text appears to be a table showing heartburn scores for a study involving two groups: Placebo (consisting of 58 participants) and RAB20mg (consisting of 59 participants). The scores are provided for different time periods, i.e., 7, 14, 21, and 28 days. The severity of the heartburn is rated on a scale of 1 to 4, where 1 is none, 2 is light, 3 is moderate, and 4 is very severe.*
FDA Label Image

Label Image (Lbl500901424)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.